Stock listing

CSE:BETR BetterLife Pharma Inc. Stock

Home listing (CSE) of BetterLife Pharma Inc.

Follow BetterLife Pharma Inc. into a list and get an email when it puts out news.

Share price · CSE:BETR

$0.25 CAD 0.00 (0.0%)

Close on Oct 30, 2026

Past year +316.7% · daily closes, Oct 30, 2025 – Oct 30, 2026, adjusted for splits
Day range
$0.245 – $0.26 CADOct 30, 2026
Volume
750,847 sharesOct 30, 2026
Market cap
$154.5M CADAt the close on Oct 30, 2026 · price × 618.0M shares outstanding
52-week range
$0.04 – $0.46 CADLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
Traded on an average day
$129,966 CADMedian day 267,985 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
BetterLife Pharma Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
CSE:BETR · Home$0.25 CAD0.00 (0.0%)750,847$0.26$0.26$0.245$0.25Close on Oct 30, 2026
OTC:BETRF$0.16 USD-0.01 (-5.9%)1,000$0.16$0.16$0.16$0.17Close on Oct 27, 2026

Daily closes

Last 3 months, Jul 30, 2026 – Oct 30, 2026 · CSE:BETR · CAD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.250.000.0%$0.26$0.26$0.245750,847
$0.25+0.01+4.2%$0.245$0.26$0.245144,000
$0.24+0.015+6.7%$0.235$0.25$0.235116,021
$0.2250.000.0%$0.23$0.23$0.2216,600
$0.2250.000.0%$0.23$0.235$0.225248,100
$0.225-0.02-8.2%$0.24$0.24$0.225345,435
$0.245-0.005-2.0%$0.25$0.26$0.23501,610
$0.25+0.05+25.0%$0.21$0.285$0.212,032,641
$0.20-0.01-4.8%$0.21$0.215$0.20144,800
$0.210.000.0%$0.21$0.225$0.21116,326
$0.21-0.015-6.7%$0.23$0.23$0.21467,301
$0.225+0.005+2.3%$0.225$0.23$0.22132,057
$0.22-0.025-10.2%$0.25$0.25$0.22456,300
$0.245-0.01-3.9%$0.26$0.26$0.245300,607
$0.255-0.015-5.6%$0.28$0.28$0.255314,343
$0.27+0.01+3.8%$0.26$0.27$0.25311,500
$0.26-0.005-1.9%$0.26$0.27$0.26129,967
$0.265-0.025-8.6%$0.295$0.295$0.265269,089
$0.29+0.025+9.4%$0.29$0.29$0.2730,701
$0.265-0.005-1.9%$0.27$0.285$0.265372,951
$0.27-0.075-21.7%$0.315$0.32$0.27921,958
$0.345+0.06+21.1%$0.30$0.345$0.2973,010
$0.285-0.025-8.1%$0.315$0.315$0.285283,489
$0.31-0.025-7.5%$0.33$0.33$0.305319,050
$0.335-0.015-4.3%$0.35$0.355$0.33198,701
$0.35+0.015+4.5%$0.335$0.35$0.335184,428
$0.335+0.015+4.7%$0.335$0.345$0.33181,700
$0.32+0.015+4.9%$0.32$0.33$0.305209,113
$0.305-0.025-7.6%$0.335$0.35$0.301,535,561
$0.33-0.03-8.3%$0.355$0.36$0.33248,618
$0.360.000.0%$0.35$0.39$0.34861,522
$0.36-0.02-5.3%$0.39$0.39$0.35505,800
$0.38-0.02-5.0%$0.40$0.40$0.36392,698
$0.40+0.06+17.6%$0.34$0.40$0.341,124,392
$0.34+0.035+11.5%$0.315$0.34$0.315184,786
$0.305+0.005+1.7%$0.30$0.31$0.30264,000
$0.30-0.005-1.6%$0.305$0.305$0.3044,015
$0.305+0.005+1.7%$0.305$0.305$0.3031,533
$0.300.000.0%$0.305$0.305$0.30615,167
$0.30+0.015+5.3%$0.285$0.31$0.28892,540
$0.285-0.005-1.7%$0.295$0.295$0.28195,000
$0.290.000.0%$0.31$0.31$0.28116,316
$0.29-0.025-7.9%$0.325$0.325$0.29854,369
$0.315+0.005+1.6%$0.345$0.345$0.29590,644
$0.31-0.06-16.2%$0.35$0.355$0.302,554,040
$0.37-0.01-2.6%$0.375$0.38$0.3539,195
$0.38+0.06+18.8%$0.32$0.38$0.30441,701
$0.32-0.005-1.5%$0.32$0.32$0.295238,893
$0.325+0.01+3.2%$0.32$0.33$0.30266,880
$0.315-0.035-10.0%$0.315$0.34$0.31169,019
$0.35-0.01-2.8%$0.35$0.365$0.33253,151
$0.36+0.06+20.0%$0.30$0.36$0.295143,750
$0.30+0.015+5.3%$0.27$0.30$0.2778,374
$0.285-0.015-5.0%$0.29$0.295$0.265251,739
$0.30-0.015-4.8%$0.31$0.32$0.3058,150
$0.315+0.03+10.5%$0.305$0.315$0.2948,275
$0.285-0.02-6.6%$0.31$0.35$0.285435,952
$0.305-0.12-28.2%$0.44$0.445$0.30742,591
$0.425+0.025+6.2%$0.42$0.46$0.41919,452
$0.40+0.035+9.6%$0.36$0.40$0.35504,343
$0.365+0.005+1.4%$0.355$0.365$0.34358,154
$0.36+0.07+24.1%$0.30$0.36$0.301,036,722
$0.29+0.05+20.8%$0.25$0.295$0.25528,230
$0.24+0.01+4.3%$0.205$0.24$0.20543,590
Ticker
CSE:BETR
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
CSE
Currency
CAD

What changed lately

Latest news

All BetterLife Pharma Inc. news

Financings

  • Public offering of common shares and pre-funded warrants

    Sep 17, 2026

    Closed: US$100M raised · C$0.25 a share · Bloom Burton Securities Inc. +1

    Dealers: Bloom Burton Securities Inc. (lead), Haywood Securities Inc.

    Buyers: Deep Track Capital (led the financing); Coastlands Capital (significant co-investment); Marshall Wace (significant co-investment); RA Capital Management (significant co-investment); Perceptive Advisors (significant co-investment); Adage Capital Management (participation); Affinity Asset Advisors (participation); Kalehua Capital (participation); Sphera Fund Management (participation); Squadron Capital Management (participation); Stonepine Capital Management (participation); Woodline Partners LP (participation)

    Use of proceeds: Phase 1A, Phase 1B and Phase 2 clinical trials of BETR-001 in cluster headache and migraine, plus working capital and general corporate purposes

    Announced Aug 24, 2026 · Terms changed Aug 28, 2026 · Closed Sep 17, 2026

Read by 6ix AI from the company's releases

Decks

BetterLife Pharma Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
70 in the last 12 months · 161 in all · newest Oct 27, 2026 · oldest 2011
Decks
5 decks · latest July 2026

Where BetterLife Pharma Inc. is listed

ListingExchangeCountryCurrency
CSE:BETR · Home listing · This pageCSECanadaCAD
OTC:BETRFOTCUnited StatesUSD
Cboe Canada:BETRCboe CanadaCanadaCAD
Frankfurt:NPAUFrankfurtGermanyEUR
LS Exchange:A2P7XNLS ExchangeGermanyEUR
Lang & Schwarz:A2P7XNLang & SchwarzGermanyEUR
gettex:NPAUgettexGermanyEUR
Stuttgart:NPAUStuttgartGermanyEUR
Munich:NPAUMunichGermanyEUR

Log in to ask 6ix AI your own questions about BetterLife Pharma Inc.